Adial Pharmaceuticals, Inc. (ADIL) — 10-Q Filings

10-Q Filings (6)

• Adial Narrows Losses, Faces Going Concern Doubt Despite Capital Influx — Nov 13, 2025 Risk: high
  ADIAL PHARMACEUTICALS, INC. reported a net loss of $1,793,651 for the three months ended September 30, 2025, a decrease from the $2,191,803 net loss in the same
• Adial Narrows Losses, Raises Capital Amidst Going Concern Doubts — Aug 13, 2025 Risk: high
  ADIAL PHARMACEUTICALS, INC. reported a net loss of $1,958,556 for the three months ended June 30, 2025, an improvement from the $2,458,298 net loss in the prior
• Adial Pharmaceuticals Files Q1 2025 10-Q — May 14, 2025 Risk: low
  Adial Pharmaceuticals, Inc. filed its quarterly report on Form 10-Q for the period ended March 31, 2025. The company, incorporated in Delaware, is focused on ph
• Adial Pharmaceuticals Files Q3 2024 10-Q — Nov 13, 2024 Risk: low
  Adial Pharmaceuticals, Inc. filed its quarterly report for the period ending September 30, 2024. The company, incorporated in Delaware, is focused on pharmaceut
• Adial Pharmaceuticals Files Q2 2024 10-Q — Aug 13, 2024 Risk: low
  Adial Pharmaceuticals, Inc. filed its 10-Q for the quarterly period ended June 30, 2024. The company, incorporated in Delaware, is based in Charlottesville, VA,
• ADial Pharmaceuticals, Inc. Files Quarterly Report on Form 10-Q — May 14, 2024 Risk: low
  ADIAL PHARMACEUTICALS, INC. (ADIL) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. ADial Pharmaceuticals, Inc. filed a Form 10-Q for the quarterly

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX